RETAINING A CLINICAL PERSPECTIVE IN MACRO LEVEL CHANGES
With
Dr Shona Sundaraj,
Group Medical Director
Medibank
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | August 2026
Dr Shona Sundaraj BAppSc (Phty), MBBS, FRACGP, MBA is Group Medical Director at Medibank, bringing over two decades of clinical and systems experience to strategy, research and stakeholder engagement. She leads the Medibank Better Health Research Hub and Chairs the Health Research Governance Committee, guiding stakeholder engagement, competitive grant rounds and partnerships with universities, translational research centres and peak bodies to support evidence based improvement in care.
Shona combines frontline clinical insight with corporate experience across health, insurance and primary care. Shona was awarded an Imperial Excellence Scholarship and completed her MBA through Imperial College Business School. She has completed executive leadership study at Harvard University. Her previous roles include senior medical positions at Zurich Financial Services and TAL, where she contributed to product innovation, risk mitigation and preventative health initiatives. She has led primary care operations through COVID19 period in primary care.
Her work is shaped by a lifelong commitment to healthy ageing as a life course priority, and to translating evidence into accessible, person-centred models of care. She has chaired both Sustainability and Research Governance groups, driven AI-enabled prevention pilots, supported medical education and worked in community volunteer clinics for vulnerable people experiencing homelessness.
A Sydney native, Shona is a mother of two and enjoys running and walking her two dogs along the harbour and beaches. Her focus in her roles as Senior Executive leader at Medibank, non-executive director and invited speaker is the practical impact that collaboration can have on the health of Australia.
Source: Supplied
Media access credit: Women’s Health MedTech Summit Australia 2026 | Medical Technology Association of Australia (MTAA)
-
From refugee to receiving multiple accolades as a community pharmacist
Sara is an experienced pharmacist, community health advocate, and the Lead Pharmacist at Pharmacy 777 Pascoe Vale in Victoria. With over 20 years in the profession, Sara has played a significant role in advancing local healthcare delivery through clinical leadership, service development, and strong community partnerships.
-
Reframing women’s health as a system-wide agenda across innovation, regulation, workforce and policy
Professor Robyn Norton AO FAHMS is one of the two Founding Directors of The George Institute for Global Health, Professor of Public Health at UNSW Sydney and Emeritus Professor of Global Health at Imperial College London. Robyn co-established The George Institute’s Global Women’s Health Program and more recently the Centre for Sex and Gender Equity in Health and Medicine, where she co-leads the Business Translation Working Group. Robyn is a director on the board of the Black Dog Institute, a member of the Women in MedTech Committee of the MTAA and a member of Chief Executive Women. She also chairs the NHMRC’s Gender Guidelines Development Committee and the Advisory Board of the Network of Excellence in Women’s Health at Imperial College London.
-
Global collaboration in pulmonary fibrosis research
Pulmonary fibrosis is a lung disease that occurs when lung tissue becomes damaged and scarred. The debilitating and fatal disease ended the life of an Australian man 8 years ago.
His son led philanthropic efforts to establish the connection between 2 Australian organisations; Lung Foundation Australia and Centre for Research Excellence in Pulmonary Fibrosis and the US based, Three Lakes Foundation. The three organisations recently announced a collaboration to create a global network for PF research.
